Loading clinical trials...
Loading clinical trials...
A Open Label, Non Randomized, Phase Two Trial in Metastatic Colorectal Cancer (mCRC) With the Combination of m FOLFIRI Plus Aflibercept as First Line Treatment: MINOAS Trial
Conditions
Interventions
5 Fluorouracil
Leucovorin
+2 more
Locations
10
Greece
University Hospital of Heraklion Crete
Heraklion, Crete, Greece
251 Air Forces Military Hospital of Athens
Athens, Greece
Anicancer Hospital of Athens "Agios Savvas"
Athens, Greece
Anticanscer Hospital of Athens "Agios Savvas"
Athens, Greece
Athens Hospital "Mitera" Hygia Polis
Athens, Greece
General Hospital of Athens "Aretaieio"
Athens, Greece
Start Date
January 1, 2016
Primary Completion Date
October 1, 2018
Completion Date
March 1, 2019
Last Updated
February 22, 2019
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Hellenic Oncology Research Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions